Recent evidence suggests that alterations in bone morphogenetic protein (BMP) signaling may influence breast cancer progression and metastasis (Liu et al., 2023); however, the specific function and regulatory targets of BMP2 in breast MCA pathogenesis are yet to be fully understood. This evidence concerns the gene BMP2 and breast carcinoma.